We control the entire process, end to end
A single platform that integrates science, lab, bioinformatics and product. That's how we cut development time and guarantee traceability between evidence and report.
“From the clinical question to a product ready to scale.”
Ten stages, one platform
Each stage runs with consistent standards and end-to-end traceability.
- 01
Goal definition
We pin down the clinical or commercial goal and the product's target audience.
- 02
Evidence review
We analyze the available scientific literature and its level of support.
- 03
Biomarker selection
We pick SNPs or epigenetic markers using explicit, documented criteria.
- 04
Panel design
We define the panel's composition, coverage and analytical architecture.
- 05
Development and validation
We validate analytical performance before processing real samples.
- 06
Sample processing
We run the panel with optimized costs and quality control.
- 07
Bioinformatics
We process the data with our own pipelines and algorithms.
- 08
Interpretation
We translate results into actionable information based on the evidence.
- 09
Report generation
We produce custom, automated reports ready for the end user.
- 10
Clinical or commercial integration
We deliver the product via API or white label, ready to scale.
Why an integrated platform
Speed
A single flow shortens new-panel development to under three months.
Traceability
Every result is traceable back to the evidence and the biomarker behind it.
Scalability
Modular architecture built to grow in volume and product catalog.
Consistency
The same standards apply from sample to final report.
Let's design your next molecular product
Tell us your clinical or commercial goal and we'll prepare a tailored proposal.